Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Neogen Corporation

Neogen Corporation (NEOG) Stock Overview

Explore Neogen Corporation’s financial performance, market position, analyst ratings, and future outlook.

NEOG●NASDAQ
HealthcareMedical - Diagnostics & Research
$11.95
$0.12(1.01%)
U.S. Market opens in 59h 53m

Neogen Corporation (NEOG)

Meyka AI Score

Z

Key Financials

Market Cap2.6B
P/E Ratio-356.92
EPS (TTM)$0.28
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$12.37
3 Months$13.98
1 Year Target$11.56

NEOG Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Neogen Corporation (NASDAQ: NEOG) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Neogen Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NEOG on the NASDAQ shows an RSI of 61.60, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $11.56 for the NASDAQ listing.

Key metrics behind Neogen Corporation's NASDAQ-traded stock include a P/E ratio of -356.92 and a market capitalization of 2.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NEOG on the NASDAQ.

Price Performance (NASDAQ: NEOG)

1-Day Change
1.01%
5-Day Change
0.50%
1-Month Change
20.34%
3-Month Change
34.88%
6-Month Change
5.47%
Year-to-Date (YTD) Change
70.96%
1-Year Change
113.39%
3-Year Change
-47.52%
5-Year Change
-72.75%
All-Time (Max) Change
2588.05%

Contact Information

https://www.neogen.com
517 372 9200
620 Lesher Place, Lansing, MI, 48912-1595

Company Facts

26,360 Employees
IPO DateAug 23, 1989
CountryUS
Actively Trading

Frequently Asked Questions